Insider trades
Cambrian BioPharma, 10% Owner of Faeth Therapeutics FTH, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $787.8K. The latest trade was on 06/01.
Cambrian BioPharma
10% Owner
- Company
- Faeth Therapeutics FTH
- First filing
- 23/03/07
- Trades
- 19 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- −$787.8K
- Last trade
- 06/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
FTH | Open-market sale | 06/01 | 06/01 | 25,000 sh2 trades | $20.02avg. | $500,542.64 | −16.1% |
FTH | Open-market sale | 25/12/09 | 25/12/10 | 6,612 sh4 trades | $8.25avg. | $54,574.77 | −4.1% |
FTH | Open-market sale | 25/12/04–25/12/05 | 25/12/08 | 21,295 sh4 trades | $10.93avg. | $232,689.97 | −11.7% |